Comparison of antinociceptive effect of the antiepileptic drug gabapentin to that of various dosage combinations of gabapentin with lamotrigine and topiramate in mice and rats

Journal of Neurosciences in Rural Practice

Volumn 2, Issue 2, 2011, Pages 130-136

  Paudel, Keshab Raj ^a   Bhattacharya, S K ^c   Rauniar, G P ^b   Das, B P ^b  

^a KATHMANDU MEDICAL COLLEGE   (Nepal)

^b B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^c UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Analgesia; Formalin assay; Gabapentin; Lamotrigine; Mechanical hyperalgesia; Radiant heat; Thermal nociception; Topiramate

Indexed keywords

CAPSAICIN; GABANTIN; GABAPENTIN; LAMETEC; LAMOTRIGINE; TOPAZ; TOPIRAMATE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; HOT PLATE TEST; HUMAN; HYPERALGESIA; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

EID: 80051866620     PISSN: 09763147     EISSN: 09763155     Source Type: Journal    
DOI: 10.4103/0976-3147.83577     Document Type: Article

References (37)

1. Davis MP, Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Pallait Care 2004;2:137-42. (Pubitemid 38560953)
2. Backonja M, Serra J. Pharmacological management of part 1: Better-studied neuropathic pain disease. Pain Med Suppl 2004;5:28-47.
3. Ahmad M, Gouke CR. Management strategies for the treatment of neuropathic pain in the elderly. Drugs Aging 2002;19:929-45. (Pubitemid 36092254)
4. Blackburn-Munro G, Erichsen HK. Antiepileptics and treatment of neuropathic pain: Evidence from animal models. Curr Pharm Des 2005;11:2961-76. (Pubitemid 41149936)
5. Backonja M. Neuromodulating drugs for the symptomatic treatment of neuropathic pain. Curr Pain Headache Rep 2004;8:212-6. (Pubitemid 38922784)
6. Guay DR. Oxacarbazepine, topiramate, zonisamide and levetiracetam: Potential use in neuropathic pain. Am J Geriatr Pharmacother 2003;1:18-37. (Pubitemid 40410984)
7. Vu TN. Current pharmacological approach to treating neuropathic pain. Curr Pain Headache Rep 2004;8:15-8.
8. Spina E, Perugi G. Antiepileptic drugs: Indication other than epilepsy. Epileptic Disord 2004;6:57-75. (Pubitemid 38808120)
9. Cartet GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 2001;12:447-59. (Pubitemid 32397211)
10. Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002;10:14-7.
11. Laughlin TM, Tram KV, Wilcox GL, Birnbaum A. Comparison of antiepileptic drugs tiagabine, lamotrigine and gabapentin in mouse models of acute, prolonged and chronic nociception. J Pharmacol Exp Ther 2002;302:1168-75. (Pubitemid 34920240)
12. Aanonsen LM, Wilcox GL. GABA A receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther 1989;248:1026-33. (Pubitemid 19100751)
13. Durand JP, Alexandre J, Guilevin L, Goldwasser F. Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy. Anticancer drugs 2005;16:587-91. (Pubitemid 40685744)
14. Goldlust A, Su TZ, Welty DF, Taylor CP, Oxender DL. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 1995;22:1-11.
15. Su TZ, Lunney E, Campbell G, Oxender DL. Transport of gabapentin, a γ-amino acid drug, by system 1 α-amino acid transporters; a comparative study in astrocytes, synaptosomes and CHO cells. J Neurochem 1995;64:2125-31.
16. Porter RJ, Meldrum BS. Antiseizure drugs. In: Katzung BG, editor. Basic and clinical pharmacology. USA: The McGraw-Hill Companies; 2004. p. 379-99.
17. Xiao W-II, Bennet GJ. Gabapentin relieves abnormal pain sensations via a spinal site of action in a rat model of painful peripheral neuropathy. Analgesia 1996;2:267-73.
18. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thomson J, et al. The effects of novel antiepileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997;324:153-60. (Pubitemid 27174600)
19. Champan V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998;75:261-72. (Pubitemid 28160137)
20. Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther 1999;288:1026-30. (Pubitemid 29254139)
21. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine a novel potential antiepileptic drug: II neurological studies on the mechanism of action. Epilepsia 1986;27:490-7. (Pubitemid 16026042)
22. Teoh H, Fowler LJ, Bowery NG. Effects of lamotrigine on the electrically evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord. Neuropharmacology 1995;34:1273-8.
23. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 1992;13:107-12.
24. Zimmermann A. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109.
25. Gilchrist HD, Allard BL, Simone DA. Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats. Pain 1996;67:179-88. (Pubitemid 26319651)
26. Bassani M, Bergamaschi M, Bolzoni PT, Villeti G. CHF3381, a novel antinociceptive agent, attenuates capsaicin-induced pain in rats. Eur J Pharmacol 2005;519:231-6. (Pubitemid 41278543)
27. Vogel HG, Vogel WH. Radiant heat and hot plate method. In: Drug discovery and evaluation. Germany: Springer-Verlag Berlin Heidelberg; 1997. p. 368-70.
28. Shimoyama N, Shimoyama M, Davis AM, Inturirrisi CE, Elliott KJ. Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci Lett 1997;222:65-7. (Pubitemid 27061093)
29. Patel S, Naeem S, Kesinglad A, Frostl W, Capogna M, Urban L, et al. The effects of GABA B agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 2001;90:217-26. (Pubitemid 32162943)
30. Dirks J, Petersen KL, Rowbotham MC, Dahl JB. Gabapentin suppresses cutaneous hyperalgesia following heat-capsaicin sensitization. Anesthesiology 2002;97:102-7. (Pubitemid 34733928)
31. Woolf CJ, Shortland P, Coggeshall RF. Peripheral-nerve injury triggers central sprouting of myelinated afferents. Nature 1992;335:75-8.
32. Field MJ, Oles RJ, Lewis AS, McClearly S, IIughes J, Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represents a novel class of selective antihyperalgesic agents. Br J Pharmacol 1997;121:1513-22. (Pubitemid 27343376)
33. Villetti G, Bergamaschi M, Bassani F, Bolzoni PT, Mairino M, Pietra C, et al. Antinociceptive activity of N-methyl-D-aspartate receptor agonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003;306:804-14. (Pubitemid 36886183)
34. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-34. (Pubitemid 37443116)
35. Ross EL. The evolving role of antiepileptic drugs in treating neuropathic pain. Neurology 2002;55(5 suppl 1):S41-6.
36. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 2005;71:483-90. (Pubitemid 40194067)
37. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27. (Pubitemid 27025878)